Tea polyphenols

About us
Green tea extract
civilization of tea
Herb extract
Biochemistry products
Chinese herb
Material base
Equipment
E-shopping
corona-fz@263.net
Chinese
BIG5

 

DOSAGE OF ANTICANCER HERBAL

PART A PART B PART C
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Pingying: Ruixiang Langdu
English: Chinese Stellera
Latin: Stellera chamaejasme L

Sources:The roots of Stellera chamaejasme L. Family Thymelacaceae.

Constituents: Containsing Stellerin, sterols, phenol compounds ,amino acids, organic acids and fischeriana A, etc.

Actions:
The inhibiting rates of alcohol extract of the herb against LLC was 70.2%, its inhibiting rates of its volatile material against Heps was 42.5%, against U14 was 50.5%, its anticancer activity was higher than that of VCR
and 5FU[21:407].

Indications: It could be used for treatment of liver, lung, intestine and breast cancers. The dry product of the herb was made of 1:1 concentration injection preparation of im. once a day, 4ml/once, one course of treatment was 3 months, after stopped treatment for l week, treatment was continued, 170 cases of lung, breast,intestine, cerebral and neuroglioma were treated , certain curative effects were observed, and no adverse reactions such as to kiduey, liver and blood formation functions were found. Among the 170 cases treated, 8 cases (5%) survived over 5 years, 4 cases (2.4%) over 4~5 years, 13 cases (7.5%) over 3~4 years, 20 cases (12%) over 2~3 years, 45 cases (25%) over 1~2years, 20 cases (12%) over 6 months to 1 year, 60 cases (35%) survived less than 6 months. It was mainly effective against lung, breast cancers, secondary against esophageal and rectum cancers, no effective for gastric cancer.

The injection preparation of the herb at 1:1 concentration of im. 4ml/once, 2 times/a day, one month was a course of treatment, treated 43 cases of primary liver cancers, 6 cases of lung cases of cancers and 5 cases of other tumors and also treated orally by the alcoholic extract of the herb made of tablets, 0.3%/tab, 4 times/a day, the total dose was 90~1620g. The injection preparation was used for the patients with thoracic-abdomino cavity injection, 20ml/once, once a week, 5 times for one course
of treatment, The results showed that among 54 cases, CR 3 PR 9, S3, CR+PR rate was 22%, the objective effective rate was 63%.

  
 

All Copy: FuZhou Corona Science & Technology Development Co.,Ltd.
Head Office Tel:  86-591-8376-9772 ;  8376-9751    Fax:  86-591-8376-9723
Copyright© 2001-2008 All right reserved